| 产品描述: | Danicopan (ACH-4471), a selective and orally active small-molecule factor D inhibitor, shows high binding affinity to human Factor D with Kd value of 0.54 nM. Danicopan (ACH-4471) inhibits alternative pathway of complement (APC) activity, has potential to block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) |
| 靶点: |
Kd: 0.54 nM (Factor D) |
| 参考文献: |
1. Yuan X, et al. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Haematologica. 2017 Mar;102(3):466-475. |
| 溶解性: |
DMSO : 250 mg/mL (430.73 mM; Need ultrasonic) |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.723 ml |
8.615 ml |
17.229 ml |
| 5 mM |
0.345 ml |
1.723 ml |
3.446 ml |
| 10 mM |
0.172 ml |
0.861 ml |
1.723 ml |
| 50 mM |
0.034 ml |
0.172 ml |
0.345 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |